Key Points The consumer healthcare specialist has inherited a long-running legal controversy. It is facing its first lawsuit in the U.K. centered on a controversial product. 10 stocks we like better than Kenvue › A potential legal headache for consumer healthcare giant Kenvue (NYSE: KVUE) was causing pain for investors on Thursday. Such troubles tend to spook the market; hence the more than 13% sell-off of Kenvue across that trading session. The S&P 500 (SNPINDEX: ^GSPC), by comparison, did much be ...